VU0400195

[1]Jones CK, et al. Discovery, synthesis, and structure-activity relationship development of a series of N-4- (2,5-dioxopyrrolidin-1-yl) phenylpicolinamides (VU0400195, ML182) : characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu (4) ) with oral efficacy in an antiparkinsonian animal model. J Med Chem. 2011 Nov 10;54 (21) :7639-47. |[2]Darren W. Engers, et al. Discovery, Synthesis, and Preclinical Characterization of N- (3-Chloro-4-fluorophenyl) -1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) . ACS Chem. Neurosci. 2016, 7, 9, 1192–1200.